Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Arielle Abovich"'
Autor:
Arielle Abovich, Daniel S. Matasic, Rhanderson Cardoso, Chiadi E. Ndumele, Roger S. Blumenthal, Ron Blankstein, Martha Gulati
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100527- (2023)
The prevalence of heart failure (HF) in the United States (U.S.) is estimated at over 6 million adults, with the incidence continuing to increase. A large proportion of the U.S. population is also at risk of HF due to the high prevalence of establish
Externí odkaz:
https://doaj.org/article/e4623c7f589d415ca9e7b78f14e53900
Autor:
Jacqueline B Vo, Anju Nohria, Aarti Asnani, Stefania Papatheodorou, Yawen Gao, Ann H. Partridge, Arielle Abovich, Mary Obasi
Publikováno v:
Cancer Causes & Control
Cancer Causes Control
Cancer causes & control : CCC, vol 32, iss 12
Cancer Causes Control
Cancer causes & control : CCC, vol 32, iss 12
Purpose Cardiotoxicity affects 5–16% of cancer patients who receive anthracyclines and/or trastuzumab. Limited research has examined interventions to mitigate cardiotoxicity. We examined the role of statins in mitigating cardiotoxicity by performin
Autor:
Arielle Abovich, Roberta Florido
Publikováno v:
JACC: Advances. 2:100283
Autor:
Aarti Asnani, Mary Obasi, Jacqueline B Vo, Arielle Abovich, Anju Nohria, Stefania Papatheodorou, Ann H. Partridge, Yawen Gao
Publikováno v:
Cancer Causes & Control. 32:1407-1409
Autor:
Ann H. Partridge, Anju Nohria, Mary Obasi, Jacqueline B Vo, Arielle Abovich, Aarti Asnani, Yawen Gao
Publikováno v:
Cancer Research. 80:P5-14
Background: Due to advances in treatment and early detection, nearly 90% of women with breast cancer are living at least 5 years following their diagnosis. Yet, there is a risk for cardiotoxicity as a result of cancer treatments such as anthracycline
Autor:
Rhanderson Cardoso, Arielle Abovich, William E. Boden, Armin Arbab-Zadeh, Ron Blankstein, Roger S. Blumenthal
Publikováno v:
JACC: Advances. 1:100006